NCT01635959已完成不适用
Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 3,170
- 试验地点
- 1
- 主要终点
- Percentage of patients scoring ≥ 8 in GERD-Q
研究概览
简要总结
The purpose of this study is to calculate the prevalence of gastroesophageal reflux disease (GERD) by mean of GERD-Q questionnaire in patients with upper gastrointestinal tract symptoms in Egypt.
详细描述
Prevalence of Gastroesophageal reflux disease (GERD) in patients with upper gastrointestinal tract symptoms in Egypt
研究设计
- 研究类型
- Observational
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years and above
- •Attending the medical office and reporting symptoms suggestive of upper gastrointestinal tract symptoms such as heartburn/regurgitation, abdominal pain, bloating, belching and nausea/vomiting.
排除标准
- •Participating on a clinical trial during the last 3 months.
- •Patients not able to read and/or understand the GERD-Q questionnaire.
- •Patients already included in the study in other participating site.
- •Patients taking PPIs or H2blockers in the l
结局指标
主要结局
Percentage of patients scoring ≥ 8 in GERD-Q
时间窗: baseline
Percentage of patients scoring ≥ 8 in GERD-Q will be considered as suffering from GERD. The GERD-Q is a potentially useful tool for family practitioners and other health care professionals in diagnosing and managing GERD without initial specialist referral or endoscopy. The Egyptian-validated version of the GERD-Q will be used for the study purposes.
次要结局
- Treatment patterns in patients diagnosed with gastroesophageal reflux disease (GERD)(baseline)
- Socio-demographic characteristics of patients diagnosed with gastroesophageal reflux disease (GERD)(baseline)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Prevalence of Gastroesophageal Reflux Disease in Primary Care Patients With Upper Gastrointestinal SymptomsGastroesophageal Reflux DiseaseNCT01020890AstraZeneca2,210
已完成
不适用
Epidemiological Studies and Risk Factor Analysis of GERD in Xiamen CityGastroesophageal Reflux DiseaseEpidemiologyRisk FactorsNCT06585176Zhongshan Hospital (Xiamen), Fudan University1,625
尚未招募
不适用
A study to find out the Proportion of Gastro Esophageal Reflux Disease (Erigunmam)- in AAGHIMCTRI/2019/07/020092Government Siddha Medical College
已完成
2 期
A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)Symptomatic Gastroespohageal Reflux DiseaseNCT00149851Novartis832
尚未招募
Unknown
A Clinical trial to study the effect of Amalaki Churna in Gastro Esophageal Reflux Disease in Ayurvedic perspectiveCTRI/2023/03/050275Government Ayurvedic College and Hospital Patna Aryabhatta Knowledge University Patna Bihar